Public sector supplier

Sciensus Pharma Services Limited public sector contracts

16 contracts held by Sciensus Pharma Services Limited end in the next 18 months. See them come up for renewal, and who else it supplies.

Is this Sciensus Pharma Services Limited? See the open tenders like the ones you win

Watch this competitor30 days free, no card needed.
22
Contracts, last 12 months
47
Contracts since 2021
15
Public sector buyers
£670k
Median contract won outright
16
Ending in 18 months
Sciensus Pharma Services Limited: contracts by end datefrom award notices with a published end date, each contract counted once

Hatched quarters fall only partly inside the next 18 months. Busiest whole quarter: Q1 2028.

Find tenders for your company

Paste your website and we score this week’s UK public sector tenders against it, each with a reason. Free, no sign-up.

  • 4 contracts end in the next 6 months
  • Has won public contracts every year since 2022
  • Won work from 5 new buyers in the last 12 months

22 contract awards published in the last 12 months, up from 14 the year before, and 47 since 2021 from 15 public sector buyers.

Sciensus Pharma Services Limited at a glance

Its most frequent public sector customer is Belfast Health and Social Care Trust, with 10 contracts.

Most of its work falls under medical equipment and pharmaceuticals.

33 of its contracts were awarded to it as the only named supplier; the remaining 14 are contracts shared with other suppliers, typically a place on a framework rather than work awarded outright.

Among the contracts it won outright where a value was published, the median is £670k.

Contracts won per quarter

Q1 254Q2 254Q3 253Q4 252Q1 263Q2 267Q3 268Q4 262

Get a free weekly email about Sciensus Pharma Services LimitedFree, by email, once a week

Competing with Sciensus Pharma Services Limited?

Track the buyers they supply and get every new notice scored against your profile before 9am, alongside the contracts they hold that are coming up for renewal.

30 days free. No card required.